Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Net Margin (2021 - 2025)

PAVmed has reported Net Margin over the past 5 years, most recently at 2261.73% for Q4 2025.

  • For Q4 2025, Net Margin fell 1572173.0% year-over-year to 2261.73%; the TTM value through Dec 2025 reached 3773.0%, down 271165.0%, while the annual FY2025 figure was 3774.0%, 484131.0% down from the prior year.
  • Net Margin for Q4 2025 was 2261.73% at PAVmed, up from 126560.0% in the prior quarter.
  • Over five years, Net Margin peaked at 221187.5% in Q1 2025 and troughed at 221800.0% in Q2 2025.
  • A 5-year average of 13101.1% and a median of 4899.33% in 2021 define the central range for Net Margin.
  • On a YoY basis, Net Margin climbed as much as 22344374bps in 2025 and fell as far as -22068580bps in 2025.
  • Year by year, Net Margin stood at 5761.67% in 2021, then crashed by -218bps to 18332.14% in 2022, then surged by 92bps to 1516.21% in 2023, then surged by 988bps to 13460.0% in 2024, then tumbled by -117bps to 2261.73% in 2025.
  • Business Quant data shows Net Margin for PAVM at 2261.73% in Q4 2025, 126560.0% in Q3 2025, and 221800.0% in Q2 2025.